Your browser doesn't support javascript.
loading
Rolling the DICEP on lymphoma salvage treatments? Choose wisely.
Balzarotti, Monica; Bagnoli, Filippo.
Afiliación
  • Balzarotti M; Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Bagnoli F; Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.
Br J Haematol ; 2024 Jul 27.
Article en En | MEDLINE | ID: mdl-39072700
ABSTRACT
Although immunotherapy is rapidly changing the treatment approach to r/r diffuse large B cell lymphoma, there is still a place for autologous stem cell transplantation in some patients. The report by Stewart et al. focuses on induction therapy and the importance of the pretransplantation phase. Commentary on Stewart et al. Canadian cancer trials group LY.17 A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-Outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP. Br J Haematol 2024 (Online ahead of print). doi 10.1111/bjh.19555.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Br J Haematol Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Br J Haematol Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido